A previous meta-analysis reported no significant association between XRCC2 Arg188His polymorphism and breast cancer risk, whereas only one specific cancer type included led to its limitation and the unexplained heterogeneity might reduce the validity of the conclusion [10]. This evidence concerns the gene XRCC2 and cancer.